120 related articles for article (PubMed ID: 8850236)
1. [Blast differentiation in a patient with chronic myeloid leukemia in blast crisis using retinoic acid].
Burgaleta C; Villalba S; Ferro MT
Sangre (Barc); 1995 Dec; 40(6):509-12. PubMed ID: 8850236
[TBL] [Abstract][Full Text] [Related]
2. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
[TBL] [Abstract][Full Text] [Related]
3. Extramedullary blast crisis of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation mimicking aggressive, translocation t(14;18)-positive B-cell lymphoma.
Kroschinsky F; Friedrich K; Hanel M; Mohr B; Langer T; Meinhardt M; Thiede C; Bornhauser M; Baretton G; Ehninger G
Ann Hematol; 2003 Jan; 82(1):47-52. PubMed ID: 12574966
[TBL] [Abstract][Full Text] [Related]
4. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of the blast phase of chronic granulocytic leukemia.
Canellos GP
Hematol Oncol Clin North Am; 1990 Apr; 4(2):359-67. PubMed ID: 2182596
[TBL] [Abstract][Full Text] [Related]
6. [Retinoic acid effect on the differentiation of blast cells in suspension].
Burgaleta C; Moreno T; Sánchez Godoy P
Sangre (Barc); 1989 Jun; 34(3):186-90. PubMed ID: 2762980
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in molecular biology of chronic myeloid leukaemia: is the pathogenetic puzzle approaching solution?
Goldman JM
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():129-30. PubMed ID: 2496882
[TBL] [Abstract][Full Text] [Related]
8. [Deletion (7)(p11p15): an infrequent abnormality in blast crisis in chronic myeloid leukemia].
Resino M; Ferro MT; García-Laraña J; García-Sagredo JM; Cabello P; López-Yarto A; San Román C
Sangre (Barc); 1994 Dec; 39(6):465-7. PubMed ID: 7855700
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all-trans-retinoic acid].
Tsurugano S; Togawa A; Soda Y; Miwa A; Takaku F; Yuo A; Yamada K; Hirai H
Rinsho Ketsueki; 1994 Jan; 35(1):36-41. PubMed ID: 8139100
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic heterochromatin markers distinguish terminally differentiated leukocytes from incompletely differentiated leukemia cells in human blood.
Popova EY; Claxton DF; Lukasova E; Bird PI; Grigoryev SA
Exp Hematol; 2006 Apr; 34(4):453-62. PubMed ID: 16569592
[TBL] [Abstract][Full Text] [Related]
11. t(8;21)(q22;q22) in blast phase of chronic myelogenous leukemia.
Yin CC; Medeiros LJ; Glassman AB; Lin P
Am J Clin Pathol; 2004 Jun; 121(6):836-42. PubMed ID: 15198355
[TBL] [Abstract][Full Text] [Related]
12. [Use of a chromosome 21 gene library in the identification of a marker chromosome in chronic myeloid leukemia].
Cabello P; Speleman F; Ferro MT; Resino M; García-Sagredo JM; San Román C; Burgaleta MC
Sangre (Barc); 1992 Dec; 37(6):457-9. PubMed ID: 1293797
[TBL] [Abstract][Full Text] [Related]
13. [Granulopoiesis and cytogenetic studies in chronic myeloid leukemia: their correlation with the clinical stage of the disease].
Bianchi de Di Risio CC; Labal de Vinuesa ML; Fernández J; Gronda M; Larripa I
Sangre (Barc); 1988 Jun; 33(3):178-83. PubMed ID: 3175814
[No Abstract] [Full Text] [Related]
14. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
[TBL] [Abstract][Full Text] [Related]
15. Lineage switch and multilineage involvement in two cases of pH chromosome-positive acute leukemia: evidence for a stem cell disease.
Cuneo A; Balboni M; Piva N; Carli MG; Tomasi P; Previati R; Negrini M; Scapoli G; Spanedda R; Castoldi G
Haematologica; 1994; 79(1):76-82. PubMed ID: 15378954
[TBL] [Abstract][Full Text] [Related]
16. Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acid.
Wiernik PH; Dutcher JP; Paietta E; Hittelman WN; Vyas R; Strack M; Castaigne S; Degos L; Gallagher RE
Leukemia; 1991 Jun; 5(6):504-9. PubMed ID: 2056773
[TBL] [Abstract][Full Text] [Related]
17. Blast crisis of chronic myelogenous leukemia exhibiting immunophenotypic features of a myeloid/natural killer cell precursor.
Murase T; Suzuki R; Tashiro K; Morishima Y; Nakamura S
Int J Hematol; 1999 Feb; 69(2):89-91. PubMed ID: 10071456
[TBL] [Abstract][Full Text] [Related]
18. A t(20;21)(q12;q22.3) in a patient with chronic myelocytic leukemia in blastic phase.
Gozzetti A; Tozzuoli D; Crupi R; Gentili S; Raspadori D; Fabbri A; Lauria F
Cancer Genet Cytogenet; 2004 Apr; 150(1):90-1. PubMed ID: 15041233
[No Abstract] [Full Text] [Related]
19. Chronic myeloid leukemia blast crisis arises from progenitors.
Michor F
Stem Cells; 2007 May; 25(5):1114-8. PubMed ID: 17218393
[TBL] [Abstract][Full Text] [Related]
20. High-resolution analysis of acquired genomic imbalances in bone marrow samples from chronic myeloid leukemia patients by use of multiple short DNA probes.
Reid AG; Tarpey PS; Nacheva EP
Genes Chromosomes Cancer; 2003 Jul; 37(3):282-90. PubMed ID: 12759926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
